CAITLIN SHEEHAN: Open Payments
NPI 1033651260 · AVON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 34 payments from 16 companies in 2025. Trend: 2023 $388 · 2024 $389 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 9 | $154 |
| Eisai Inc. | 3 | $80 |
| Neurocrine BioSciences, Inc. | 3 | $73 |
| Lundbeck LLC | 3 | $60 |
| ABBVIE INC. | 3 | $57 |
| InSightec,Inc | 1 | $54 |
| Aucta Pharmaceuticals, Inc. | 2 | $46 |
| ACADIA Pharmaceuticals Inc | 2 | $32 |
| SK Life Science, Inc. | 1 | $29 |
| KYOWA KIRIN, INC. | 1 | $22 |
Products named: Briviact, Leqembi, INGREZZA, Exablate, Motpoly XR, VYALEV, VYEPTI, Nayzilam.
Industry payments across IN — which companies pay providers there.
